Intensive breast screening in BRCA2 mutation carriers is associated with reduced breast cancer specific and all cause mortality.
Authors
Evans, D Gareth RHarkness, E
Howell, Anthony
Wilson, M
Hurley, E
Holmen, M
Tharmaratnam, K
Hagen, A
Lim, Y
Maxwell, A J
Moller, P
Affiliation
Genesis Breast Cancer Prevention Centre and Nightingale Breast Screening Centre, University Hospital of South Manchester, Southmoor Road, Wythenshawe, ManchesterIssue Date
2016
Metadata
Show full item recordAbstract
The addition of annual MRI screening to mammography has heightened optimism that intensive screening along with improved treatments may substantially improve life expectancy of women at high risk of breast cancer. However, survival data from BRCA2 mutation carriers undergoing intensive combined breast screening are scarce.Citation
Intensive breast screening in BRCA2 mutation carriers is associated with reduced breast cancer specific and all cause mortality. 2016, 14:8 Hered Cancer Clin PractJournal
Hereditary Cancer in Clinical PracticeDOI
10.1186/s13053-016-0048-3PubMed ID
27087880Type
ArticleLanguage
enISSN
1731-2302ae974a485f413a2113503eed53cd6c53
10.1186/s13053-016-0048-3
Scopus Count
Collections
Related articles
- Relevance and efficacy of breast cancer screening in BRCA1 and BRCA2 mutation carriers above 60 years: a national cohort study.
- Authors: Saadatmand S, Vos JR, Hooning MJ, Oosterwijk JC, Koppert LB, de Bock GH, Ausems MG, van Asperen CJ, Aalfs CM, Gómez Garcia EB, Meijers-Heijboer H, Hoogerbrugge N, Piek M, Seynaeve C, Verhoef C, Rookus M, Tilanus-Linthorst MM, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON)
- Issue date: 2014 Dec 15
- Breast cancer detection and tumor characteristics in BRCA1 and BRCA2 mutation carriers.
- Authors: Krammer J, Pinker-Domenig K, Robson ME, Gönen M, Bernard-Davila B, Morris EA, Mangino DA, Jochelson MS
- Issue date: 2017 Jun
- Cost-effectiveness of screening BRCA1/2 mutation carriers with breast magnetic resonance imaging.
- Authors: Plevritis SK, Kurian AW, Sigal BM, Daniel BL, Ikeda DM, Stockdale FE, Garber AM
- Issue date: 2006 May 24
- Breast cancer screening in BRCA1 and BRCA2 mutation carriers after risk reducing salpingo-oophorectomy.
- Authors: Fakkert IE, Jansen L, Meijer K, Kok T, Oosterwijk JC, Mourits MJ, de Bock GH
- Issue date: 2011 Aug
- Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination.
- Authors: Warner E, Plewes DB, Hill KA, Causer PA, Zubovits JT, Jong RA, Cutrara MR, DeBoer G, Yaffe MJ, Messner SJ, Meschino WS, Piron CA, Narod SA
- Issue date: 2004 Sep 15